4//SEC Filing
Sibold William John 4
Accession 0000950170-24-007347
CIK 0001157601other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 3:24 PM ET
Size
9.9 KB
Accession
0000950170-24-007347
Insider Transaction Report
Form 4
Sibold William John
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-01-23+12,250→ 62,250 total - Award
Stock Option (Right to Buy)
2024-01-23+18,459→ 18,459 totalExercise: $229.00Exp: 2031-01-23→ Common Stock (18,459 underlying) - Award
Market Stock Unit
2024-01-23+12,250→ 12,250 total→ Common Stock (12,250 underlying)
Footnotes (3)
- [F1]Represents a grant of restricted stock units, which vest as to 25% of the shares on each of January 23, 2025, January 23, 2026, January 23, 2027 and January 23, 2028, provided the Reporting Person continues in service with the Issuer on each such date.
- [F2]The option vests as to 25% of the shares on the first anniversary of the date of grant (January 23, 2025) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.
- [F3]Each market stock unit, which is performance-based, represents the contingent right to receive one share of common stock. The amount reported represents the target number of shares which may be issued upon vesting. The market stock units will vest upon certification concerning the Company's stock price performance measured against biotechnology stock index companies for the entire performance period ending December 31, 2026.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001518611
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 3:24 PM ET
- Size
- 9.9 KB